Zolpidem MR + Zolpidem
Phase 3Completed 1 views this week 0 watching⚡ Active
Interest: 40/100
40
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Sleep Initiation and Maintenance Disorders
Conditions
Sleep Initiation and Maintenance Disorders, Sleep Disorders
Trial Timeline
Feb 1, 2006 → Nov 1, 2007
NCT ID
NCT00283946About Zolpidem MR + Zolpidem
Zolpidem MR + Zolpidem is a phase 3 stage product being developed by Astellas Pharma for Sleep Initiation and Maintenance Disorders. The current trial status is completed. This product is registered under clinical trial identifier NCT00283946. Target conditions include Sleep Initiation and Maintenance Disorders, Sleep Disorders.
What happened to similar drugs?
20 of 20 similar drugs in Sleep Initiation and Maintenance Disorders were approved
Approved (20) Terminated (2) Active (0)
Hype Score Breakdown
Clinical
17
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00283946 | Phase 3 | Completed |
Competing Products
20 competing products in Sleep Initiation and Maintenance Disorders